President Donald Trump warned drugmakers in a private meeting that tariffs are coming and said companies should hustle to ...

The DOJ backs Medicare price negotiations amidst a Novartis lawsuit, while President Trump vows to lower U.S. drug costs.

Medicare's new drug price negotiation program aims to save billions for the government and seniors. Starting in 2026, this initiative could significantly reduce out-of-pocket costs for millions of ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

After turning over more than 1,300 documents to the Federal Trade Commission, the fast food giant is turning its attention to subpoenas from pharmacy benefit managers the agency accuses of ...

Ozempic, Rybelsus and Wegovy. These three medications are Type 2 diabetes drugs that are also used to treat cardiovascular disease and obesity. Between October 2023 and October 2024, the cost of the ...

The U.S. Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...

The Trump administration is moving forward with the defense of a Biden-era plan that allows Medicare to negotiate drug prices ...

Pharmacy benefits managers, or PBMs, are meant to act as a middleman between drug manufacturers and insurance companies to ...

China’s share of the global drug development pipeline grew from 3% in 2013 to 28% in 2023, positioning China as the ...

As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...

U.S. President Donald Trump is set to meet with top pharmaceutical executives on Thursday, a White House official confirmed. The discussions will focus on Medicare drug price negotiations, pharmacy ...